Facilitated By

San Antonio Medical Foundation

PHASE III MULTICENTER, TWO-PHASE, MULTI-DOSE, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF ZS (MICROPOROUS, FRACTIONATED, PROTONATED ZIRCONIUM SILICATE)...

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Qunibi,Wajeh Y
Funded by
ZS PHARMA
Research Start Date
Status
Inactive
Clinical Care
Drug Discovery
Diabetes and Obesity